Clinical Trials Logo

Filter by:
NCT ID: NCT04800757 Completed - Work-related Injury Clinical Trials

VALES+Tú: Targeting Psychosocial Stressors to Reduce Latino Day Laborers (LDL) Injury Disparities

Start date: May 11, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy of VALES+Tú in reducing hazardous exposures at work and to determine the mediating effect of psychosocial stressors on VALES+Tú primary outcomes

NCT ID: NCT04800744 Completed - Quality of Life Clinical Trials

Aromatherapy for Improving Post-Surgical Quality of Life

Start date: March 22, 2021
Phase: N/A
Study type: Interventional

Pre-operative anxiety is a very common condition that plagues many patients prior to undergoing surgery. Anxious patients are most frequently treated with sedatives in the perioperative period, which can have a negative impact on post-operative recovery, especially when combined with narcotic pain medications. Pre-operative anxiety, depression and catastrophizing have been shown to be factors leading to an increase of up to 50% of postoperative pain and opioid requirement. Therefore, the control of mood disorders prior to surgery may help with the perioperative pain management and postoperative opioid requirement. The use of essential oils in aromatherapy have long been associated with psychological wellness, and anecdotal reports suggest that aromatherapy, specifically lavender scent, may reduce anxiety. This study will assess the role of the elequil aromatab #373 Lavender-Peppermint in improving post-surgical quality of life in patients undergoing unilateral hip replacement surgery and in patients undergoing unilateral or bilateral mastectomy. Additionally, this study will follow subjects through their perioperative course to measure to what degree the aromatherapy intervention helps to reduce instances of post-operative nausea and vomiting (PONV) and opioid requirement following surgery.

NCT ID: NCT04800614 Completed - Healthy Adults Clinical Trials

A Study to Explore the Effect of Food Before a Single Dose of Sitravatinib

Start date: March 15, 2021
Phase: Phase 1
Study type: Interventional

An Open-label, Randomized, Three-period, Crossover Study of the Effect of Food on the Pharmacokinetics of a Single Oral Dose of Sitravatinib in Healthy Adult Subjects

NCT ID: NCT04800510 Completed - Healthy Clinical Trials

Iterative Design of Custom Dynamic Orthoses

PRMRP-Norms
Start date: April 21, 2021
Phase: N/A
Study type: Interventional

The proposed study evaluates the effect of carbon fiber brace design on forces across the ankle joint. It is expected that carbon fiber braces can be designed to reduce forces in the ankle. In this study, brace geometry will be varied to determine how these changes influence the forces experienced by ankle cartilage. The purpose of this study is to refine a pre-existing musculoskeletal model and finalize the procedures for inputting multiple data sources into the model to evaluate ankle articular contact stresses.

NCT ID: NCT04800432 Completed - Pediatric Obesity Clinical Trials

Adapting Diet and Action for Everyone (ADAPT+)

ADAPT+
Start date: March 6, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to refine and optimize an obesity intervention with rural underserved Latino children and their parents that combines a standard family-based behavioral approach, the "gold standard" for pediatric obesity treatment, with a mindfulness approach focusing on stress reduction (now ADAPT+).

NCT ID: NCT04800354 Completed - Pain Clinical Trials

Brief Nurse-led Mindfulness Based Intervention

Start date: February 22, 2021
Phase: N/A
Study type: Interventional

This is a single-site, two-arm, parallel-group randomized clinical trial (RCT). The feasibility, acceptability, and clinical effects of the nurse-led, very brief, preoperative mindfulness based intervention for hip and knee replacement patients will be investigated relative to nurse-led preoperative pain psychoeducation. A secondary sub-analysis will compare two different styles of mindfulness practice (mindfulness of breath vs. mindfulness of pain) relative to preoperative pain psychoeducation.

NCT ID: NCT04800315 Completed - Dermatitis, Atopic Clinical Trials

A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

Start date: May 14, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of 3 dose regimen of CC-93538 in adult participants with moderate to severe Atopic Dermatitis (AD).

NCT ID: NCT04800237 Completed - Performance Anxiety Clinical Trials

Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety

Start date: February 23, 2021
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in male and female participants with performance anxiety.

NCT ID: NCT04800211 Completed - Tobacco Use Clinical Trials

Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products

Start date: January 17, 2017
Phase: N/A
Study type: Interventional

The purpose of this study was to estimate changes in biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH) in adult cigarette smokers (AS) who switched to using an e-vapor product (EVP) relative to adult smokers who continue smoking exclusively.

NCT ID: NCT04800185 Completed - Atopic Dermatitis Clinical Trials

Characterizing Skin Microbiome Change in Atopic Dermatitis

Start date: March 23, 2021
Phase: Early Phase 1
Study type: Interventional

Atopic dermatitis (AD), also known as eczema, is an inflammatory disease of the skin affecting a large proportion of the pediatric and adult patient population. Chronic itching and eczematous lesions lead to a high burden of disease and associated patient morbidity with higher infection rates, emotional stress and associated psychological disease. The microbiome community contributes to human health through several mechanisms. Current research suggests that derangements in the normal microbiota may lead to inflammatory bowel disease, allergy, and metabolic syndromes. Specific to dermatology, new literature has demonstrated that changes in the microbiome may play a role in the development of atopic dermatitis. With this study, the investigators hope to characterize the baseline atopic dermatitis skin microbiome and monitor the evolution of the participants skin microbiome during and after treatment with anti-inflammatory topical medications, specifically the Food and Drug Administration (FDA)-approved phosphodiesterase inhibitor, crisaborole ointment 2% (Eucrisa).